BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Diagnosis
8 results:

  • 1. Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and
    Palafox-Mariscal LA; Ortiz-Lazareno PC; Jave-Suárez LF; Aguilar-Lemarroy A; Villaseñor-García MM; Cruz-Lozano JR; González-Martínez KL; Méndez-Clemente AS; Bravo-Cuellar A; Hernández-Flores G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445768
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Photodynamic Therapy and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with AuNPs.
    Zhang W; Lu Y; Zang Y; Han J; Xiong Q; Xiong J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163150
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. In vivo Multi-scale Photoacoustic Imaging Guided Photothermal Therapy of Cervical cancer based on Customized Laser System and Targeted Nanoparticles.
    Qiu T; Lan Y; Wei Z; Zhang Y; Lin Y; Tu C; Mao G; Zhang L; Yang B; Zhang J
    Int J Nanomedicine; 2021; 16():2879-2896. PubMed ID: 33883896
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer.
    Abbink K; Zusterzeel PLM; Geurts-Moespot A; van der Steen R; Span PN; Sweep FCGJ
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1725-1735. PubMed ID: 32394054
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Gokden M; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Br J Cancer; 2004 May; 90(9):1814-24. PubMed ID: 15208622
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
    Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
    Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proliferation in "atypical" atrophic pap smears.
    Bulten J; de Wilde PC; Boonstra H; Gemmink JH; Hanselaar AG
    Gynecol Oncol; 2000 Nov; 79(2):225-9. PubMed ID: 11063649
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chemotherapeutic approach to uterine papillary serous carcinoma.
    Hamaguchi K; Komai K; Sakihama H; Okura N; Nagasue N; Nishida T; Yakushiji M
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):367-72. PubMed ID: 2129190
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.